STOCK TITAN
  1. Home
  2. BVXV

BVXV (BVXV) Stock Price, News & Analysis

BVXV

Company Description

This page collects what Stock Titan holds for BVXV, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
—

Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG

—

Scinai leadership to attend BIO-Europe Spring 2024

conferences
—

Scinai Welcomes Liat Halpert as Head of Business Development and Sales

—

Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds

offering
—

Scinai Immunotherapeutics Regains Compliance with Nasdaq's Stockholders' Equity Rule

+3.82%

BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics

BVXV has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 4 with negative movement. Key topics include conferences, offering, earnings. View all BVXV news →

SEC Filings

View All

No SEC filings available for BVXV.

Financial Highlights

—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months